A prevalence study of platelet alloantibodies in multiply transfused thrombocytopenic patients in HUSM
| dc.contributor.author | Mahmood, Wan Haslindawani Wan | |
| dc.date.accessioned | 2019-09-08T08:45:38Z | |
| dc.date.available | 2019-09-08T08:45:38Z | |
| dc.date.issued | 2004 | |
| dc.description.abstract | ACKGROUND: Multiply transfused patients are frequently subjected to platelet alloimmunization. These platelet alloantibodies produced can result in refractoriness to platelet transfusion. STUDY DESIGN AND METHODS: Ninety five thrombocytopenic (platelet count <1 00 x 1 09/1) and multilply transfused (more than 2 times transfusion of any blood component with last transfusion more than 2 weeks prior to the study) patients were recruited prospectively. The blood samples were tested using a Solid Phase system (Capture P). RESULTS: There were 45 males (47.4%) and 50 females (52.6%) recruited with ages from 3 to 90 years. The frequency of transfusions ranged from 10-168. Seven patients (7.4%) were detected to have platelet alloantibodies, predominantly anti-HPA-5b in 4 patients (4.2%). Three of them (3.2%) showed a non-specific pattern. Six patients (6.3%) had received packed cells less than 20 units and another 1 (1.1%) received more than 20 units of packed cells. Four patients (4.2%) received platelet transfusion of less than 20 units and another 3 patients (3.2%) received more than 20 unit platelets. CONCLUSION: The study may have future implications for the selection of platelet donors for alloimmunized recipients in HUSM. | en_US |
| dc.identifier.uri | http://hdl.handle.net/123456789/8846 | |
| dc.language.iso | en | en_US |
| dc.publisher | Pusat Pengajian Sains Perubatan, Universiti Sains Malaysia | en_US |
| dc.subject | Multiply transfused | en_US |
| dc.title | A prevalence study of platelet alloantibodies in multiply transfused thrombocytopenic patients in HUSM | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: